$159.62
$0.00 (0.00%)
End-of-day quote: 04/26/2024
NYSE:ABBV
AbbVie Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$54.32B | $58.05B | $56.20B | $45.80B | $33.27B | $32.75B | $28.22B | $25.64B | $22.86B | $19.96B | $18.79B | $18.38B | |
| GM % | Gross Margin % |
|
69.21% | 71.53% | 71.33% | 69.31% | 77.64% | 76.44% | 76.30% | 77.40% | 81.46% | 78.01% | 75.62% | 75.47% | |
| OM | Operating Margin |
|
32.51% | 39.54% | 37.17% | 34.27% | 42.83% | 36.40% | 36.41% | 37.53% | 38.74% | 27.56% | 32.02% | 36.03% | |
| EPS | Earnings Per Share |
|
$0.00 | $11.11 | $13.77 | $12.70 | $10.56 | $8.94 | $7.91 | $5.60 | $4.82 | $4.29 | $3.32 | $3.14 | $3.35 |
| Div. | Dividends |
|
$5.99 | $5.71 | $5.31 | $4.84 | $4.39 | $3.95 | $2.63 | $2.35 | $2.10 | $1.75 | $1.60 | $1.60 | |
| PR % | Payout Ratio % |
|
53.92% | 41.47% | 41.81% | 45.83% | 49.11% | 49.94% | 46.96% | 48.76% | 48.95% | 52.71% | 50.96% | 47.76% | |
| Sha. | Shares |
|
1765.94m | 1769.18m | 1768.34m | 1765.13m | 1478.91m | 1478.82m | 1592.13m | 1592.51m | 1609.89m | 1591.39m | 1,587m | 1577.33m | |
| OCF | Operating Cash Flow |
|
$22.84B | $24.94B | $22.78B | $17.59B | $13.32B | $13.43B | $9.96B | $7.04B | $7.54B | $3.55B | $6.27B | $6.35B | |
| FCF | Free Cash Flow |
|
$19.54B | $24.25B | $21.99B | $16.79B | $12.77B | $12.79B | $9.43B | $6.56B | $7.00B | $2.94B | $5.78B | $6.01B | |
| FCFS | Free Cash Flow Per Share |
|
$12.48 | $13.69 | $12.42 | $10.07 | $8.62 | $8.30 | $5.91 | $4.05 | $4.31 | $1.84 | $3.63 | $3.81 |
